Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.
Busse, Laurence W
Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options. [electronic resource] - Critical care (London, England) 02 2020 - 36 p. digital
Publication Type: Journal Article; Review
1466-609X
10.1186/s13054-020-2743-8 doi
Adrenal Cortex Hormones--therapeutic use
Angiotensin II--therapeutic use
Ascorbic Acid--therapeutic use
Cardiac Surgical Procedures--adverse effects
Dopamine--therapeutic use
Enzyme Inhibitors--therapeutic use
Epinephrine--therapeutic use
Humans
Methylene Blue--therapeutic use
Norepinephrine--therapeutic use
Phenylephrine--therapeutic use
Sympathomimetics--therapeutic use
Vascular Resistance--drug effects
Vasoconstrictor Agents--therapeutic use
Vasoplegia--drug therapy
Vasopressins--therapeutic use
Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options. [electronic resource] - Critical care (London, England) 02 2020 - 36 p. digital
Publication Type: Journal Article; Review
1466-609X
10.1186/s13054-020-2743-8 doi
Adrenal Cortex Hormones--therapeutic use
Angiotensin II--therapeutic use
Ascorbic Acid--therapeutic use
Cardiac Surgical Procedures--adverse effects
Dopamine--therapeutic use
Enzyme Inhibitors--therapeutic use
Epinephrine--therapeutic use
Humans
Methylene Blue--therapeutic use
Norepinephrine--therapeutic use
Phenylephrine--therapeutic use
Sympathomimetics--therapeutic use
Vascular Resistance--drug effects
Vasoconstrictor Agents--therapeutic use
Vasoplegia--drug therapy
Vasopressins--therapeutic use